lomustine
Selected indexed studies
- Lomustine and Bevacizumab in Progressive Glioblastoma. (N Engl J Med, 2017) [PMID:29141164]
- Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma. (J Feline Med Surg, 2021) [PMID:33176543]
- How did lomustine become standard of care in recurrent glioblastoma? (Cancer Treat Rev, 2020) [PMID:32408220]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Lomustine and Bevacizumab in Progressive Glioblastoma. (2017) pubmed
- Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma. (2021) pubmed
- How did lomustine become standard of care in recurrent glioblastoma? (2020) pubmed
- Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial. (2019) pubmed
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial. (2014) pubmed
- Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. (2016) pubmed
- TRAF7 knockdown induces cellular senescence and synergizes with lomustine to inhibit glioma progression and recurrence. (2025) pubmed
- Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen? (2015) pubmed
- LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma. (2018) pubmed
- Lomustine-temozolomide combination efficacious in newly diagnosed glioblastoma. (2019) pubmed